Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
COMPLETED
NCT07880314
PHASE4

Maternal Fatigue After Postpartum Anemia Treatment With Intravenous Ferric Carboxymaltose and Oral Iron Therapy

Sponsor: Pakistan Air Force (PAF) Hospital Islamabad

View on ClinicalTrials.gov

Summary

Postpartum Anemia is common after childbirth and may contribute to tiredness and reduced wellbeing in mothers.This randomized controlled trial will compare two treatments for postpartum iron deficiency:intravenous ferric carboxymaltose and oral iron therapy .This study will assess whether intravenous ferric carboxymaltose provides greater improvement in maternal fatigue during the first 6 weeks after childbirth compared to oral iron.Secondary outcomes will be assessment of depressive symptoms and breastfeeding self efficacy .Eligible postpartum women with iron deficiency anemia will be randomly assigned to receive either intravenous ferric carboxymaltose or oral iron therapy and will be followed for six weeks.The study hypothesis is that intravenous ferric carboxymaltose will result in greater improvement in maternalfatigue and may also effect breastfeeding self efficacy .

Official title: Maternal Fatigue After Postpartum Anemia Treatment With Intravenous Ferric Carboxymaltose Versus Oral Iron Therapy

Key Details

Gender

FEMALE

Age Range

18 Years - 40 Years

Study Type

INTERVENTIONAL

Enrollment

134

Start Date

2026-04-20

Completion Date

2026-09-20

Last Updated

2026-10-19

Healthy Volunteers

No

Interventions

DRUG

INTRAVENOUS FERRIC CARBOXYMALTOSE

Intravenous ferric carboxymaltose is administered as a single dose according to calculated iron deficit within 48hrs after postpartum

DRUG

oral iron therapy

participants will receive oral ferrous sulphate tablets providing 200mg elemental iron daily till required

Locations (1)

PAF hospital islamabad

Islamabad, Punjab Province, Pakistan